The aim of the study was to examine the plasma levels of adiponectin, leptin, and resistin in patients with psoriasis and their correlations with disease activity parameters: Psoriasis Activity Severity Index (PASI), Dermatology Life Quality Index (DLQI) and Body Surface Area (BSA) index, as well as selected clinical parameters. This evidence concerns the gene ADIPOQ and psoriasis.